Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations

被引：47

作者：

Marroni, F

Aretini, P

D'Andrea, E

Caligo, MA

Cortesi, L

Viel, A

Ricevuto, E

Montagna, M

Cipollini, G

Ferrari, S

Santarosa, M

Bisegna, R

Bailey-Wilson, JE

Bevilacqua, G

Parmigiani, G

Presciuttini, S

机构：

[1] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA

[2] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21205 USA

[3] NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA

[4] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy

[5] IRCCS, Oncol Referral Ctr, Aviano, PN, Italy

[6] Univ Modena & Reggio Emilia, Sect Biol Chem, Dept Biomed Sci, Modena, Italy

[7] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Modena, Italy

[8] Univ Padua, IST, Sect Viral & Mol Oncol, Padua, Italy

[9] Univ Padua, Dept Oncol & Surg Sci, Sect Oncol, Padua, Italy

[10] Univ Pisa, Ctr Stat Genet, Pisa, Italy

[11] Univ Pisa, Sect Pathol, Dept Oncol Transplants & New Technol Med, Pisa, Italy

来源：

JOURNAL OF MEDICAL GENETICS | 2004年 / 41卷 / 04期

关键词：

D O I：

10.1136/jmg.2003.013623

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：278 / 285

页数：8

共 40 条

[1]

*AM SOC CLIN ONC, 2002, POL STAT GEN TEST CA

[2]

[Anonymous], 2002, MODELING MED DECISIO

[3] Different expressivity of BRCA1 and BRCA2:: analysis of 179 Italian pedigrees with identified mutation [J].

Aretini, P ;

D'Andrea, E ;

Pasini, B ;

Viel, A ;

Costantini, RM ;

Cortesi, L ;

Ricevuto, E ;

Agata, S ;

Bisegna, R ;

Boiocchi, M ;

Caligo, MA ;

Chieco-Bianchi, L ;

Cipollini, G ;

Crucianelli, R ;

D'Amico, C ;

Federico, M ;

Ghimenti, C ;

De Giacomi, C ;

De Nicolo, A ;

Della Puppa, L ;

Ferrari, S ;

Ficorella, C ;

Iandolo, D ;

Manoukian, S ;

Marchetti, P ;

Marroni, F ;

Menin, C ;

Montagna, M ;

Ottini, L ;

Pensotti, V ;

Pierotti, M ;

Radice, P ;

Santarosa, M ;

Silingardi, V ;

Turchetti, D ;

Bevilacqua, G ;

Presciuttini, S .

BREAST CANCER RESEARCH AND TREATMENT, 2003, 81 (01) :71-79

[4] BRCA1 and BRCA2 mutations in a population-based study of male breast cancer -: art. no. R2 [J].

Basham, VM ;

Lipscombe, JM ;

Ward, JM ;

Gayther, SA ;

Ponder, BAJ ;

Easton, DF ;

Pharoah, PDP .

BREAST CANCER RESEARCH, 2002, 4 (01) :R2

[5] BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].

Berry, DA ;

Iversen, ES ;

Gudbjartsson, DF ;

Hiller, EH ;

Garber, JE ;

Peshkin, BN ;

Lerman, C ;

Watson, P ;

Lynch, HT ;

Hilsenbeck, SG ;

Rubinstein, WS ;

Hughes, KS ;

Parmigiani, G .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712

[6] Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history [J].

Berry, DA ;

Parmigiani, G ;

Sanchez, J ;

Schildkraut, J ;

Winer, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :227-238

[7] BRCA1 and BRCA2 and breast cancer incidence: A review [J].

Bishop, DT .

ANNALS OF ONCOLOGY, 1999, 10 :113-119

[8] THE CALCULATION OF BREAST-CANCER RISK FOR WOMEN WITH A FIRST DEGREE FAMILY HISTORY OF OVARIAN-CANCER [J].

CLAUS, EB ;

RISCH, N ;

THOMPSON, WD .

BREAST CANCER RESEARCH AND TREATMENT, 1993, 28 (02) :115-120

[9]

CLAUS EB, 1991, AM J HUM GENET, V48, P232

[10]

CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO

← 1 2 3 4 →